MetaADEDB 2.0 @ LMMD
5-O-[1-[3,3-Diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydron;chloride
(WMFYOYKPJLRMJI-UHFFFAOYSA-N)
Structure
SMILES
COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OC(CN(CCC(c1ccccc1)c1ccccc1)C)(C)C)C.Cl
Molecular Formula:
C36H42ClN3O6
Molecular Weight:
648.188
Log P:
8.1324
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
113.69
CAS Number(s):
100427-27-8; 132866-11-6
Synonym(s)
1.
5-O-[1-[3,3-Diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydron;chloride
2.
3,3-Diphenylpropyl-[2-[5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carbonyl]oxy-2-methylpropyl]-methylazanium;chloride
3.
Lercanidipine hydrochloride
External Link(s)
PubChem Compound57516037
10532254
157917
ChEBI31771
CHEMBLCHEMBL2106419
KEGGdr:D01849
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Hypertensive crisisFAERS: 1US FAERS
2Therapy partial responderFAERS: 1US FAERS
3Abdominal tendernessOFFSIDES
4AcidosisOFFSIDES
5AgraphiaOFFSIDES
6Alanine Aminotransferase IncreasedOFFSIDES
7AlveolitisOFFSIDES
8AngiodysplasiaOFFSIDES
9AngioedemaOFFSIDES
10Ankle FractureOFFSIDES
11Anti factor V antibody positiveOFFSIDES
12AnuriaOFFSIDES
13ApathyOFFSIDES
14Arterial bruitOFFSIDES
15ArteriosclerosisOFFSIDES
16Arteriovenous fistula thrombosisOFFSIDES
17Atrial hypertrophyOFFSIDES
18Atrial thrombosisOFFSIDES
19Blood 1,25-dihydroxycholecalciferol decreasedOFFSIDES
20Blood aldosterone increasedOFFSIDES
21Blood chloride decreasedOFFSIDES
22Blood creatine increasedOFFSIDES
23Blood creatine phosphokinase increasedOFFSIDES
24Blood creatinine decreasedOFFSIDES
25Blood creatinine increasedOFFSIDES
26Blood fibrinogen increasedOFFSIDES
27Blood glucose decreasedOFFSIDES
28Blood pressure inadequately controlledOFFSIDES
29Blood sodium abnormalOFFSIDES
30Blood sodiumOFFSIDES
31Blood urea increasedOFFSIDES
32Blood uric acidOFFSIDES
33Body height below normalOFFSIDES
34BradycardiaOFFSIDES
35Brain HypoxiaOFFSIDES
36Bronchial ObstructionOFFSIDES
37Bronchoalveolar lavage abnormalOFFSIDES
38Bronchopulmonary DysplasiaOFFSIDES
39Bulbar palsyOFFSIDES
40Cardiovascular insufficiencyOFFSIDES
41Chest PainOFFSIDES
42CholelithotomyOFFSIDES
43Chronic left ventricular failureOFFSIDES
44Chronic ulcerative colitisOFFSIDES
45Circulating anticoagulant positiveOFFSIDES
46Clostridium difficile colitisOFFSIDES
47Coagulation factor V level decreasedOFFSIDES
48ColectomyOFFSIDES
49Complication of device removalOFFSIDES
50Concomitant disease progressionOFFSIDES
51ConfabulationOFFSIDES
52Congenital mitochondrial cytopathyOFFSIDES
53Conjunctival irritationOFFSIDES
54Creatinine renal clearance decreasedOFFSIDES
55Cytolytic hepatitisOFFSIDES
56DehydrationOFFSIDES
57Dermo-hypodermitisOFFSIDES
58Diabetic RetinopathyOFFSIDES
59Dialysis device complicationOFFSIDES
60DuodenitisOFFSIDES
61DysphoniaOFFSIDES
62Eczema weepingOFFSIDES
63EczemaOFFSIDES
64Ejection Fraction DecreasedOFFSIDES
65Electrocardiogram T wave peakedOFFSIDES
66Electrocardiogram repolarisation abnormalityOFFSIDES
67Electromechanical dissociationOFFSIDES
68Enteritis necroticansOFFSIDES
69EnteritisOFFSIDES
70Enterococcal sepsisOFFSIDES
71EnuresisOFFSIDES
72EpicondylitisOFFSIDES
73EpilepsyOFFSIDES
74EpistaxisOFFSIDES
75Erosive gastritisOFFSIDES
76Escherichia sepsisOFFSIDES
77Escherichia urinary tract infectionOFFSIDES
78Eye inflammationOFFSIDES
79Febrile NeutropeniaOFFSIDES
80Febrile bone marrow aplasiaOFFSIDES
81Femoral artery occlusionOFFSIDES
82GalactorrheaOFFSIDES
83Gamma-Glutamyltransferase IncreasedOFFSIDES
84GammopathyOFFSIDES
85General physical health deteriorationOFFSIDES
86Genital burning sensationOFFSIDES
87Gingival HypertrophyOFFSIDES
88GlobulinuriaOFFSIDES
89GlossitisOFFSIDES
90GranulocytosisOFFSIDES
91GranulomaOFFSIDES
92HemiparesisOFFSIDES
93HemiplegiaOFFSIDES
94HistologyOFFSIDES
95Hypertensive heart diseaseOFFSIDES
96HyperventilationOFFSIDES
97HypoparathyroidismOFFSIDES
98HypoxiaOFFSIDES
99Idiosyncratic drug reactionOFFSIDES
100Ileal ulcerOFFSIDES
101Implantable defibrillator insertionOFFSIDES
102Inflammatory painOFFSIDES
103Infusion site mobility decreasedOFFSIDES
104Injection site hypersensitivityOFFSIDES
105Injection site infectionOFFSIDES
106Intermittent ClaudicationOFFSIDES
107Intestinal infarctionOFFSIDES
108Karnofsky scale worsenedOFFSIDES
109Kidney FailureOFFSIDES
110LipaseOFFSIDES
111Liver AbscessOFFSIDES
112LividityOFFSIDES
113Lung consolidationOFFSIDES
114MeningorrhagiaOFFSIDES
115Metabolic acidosisOFFSIDES
116Mixed hepatocellular-cholestatic injuryOFFSIDES
117MonoparesisOFFSIDES
118Motor retardationOFFSIDES
119Multi-organ disorderOFFSIDES
120Mycosis FungoidesOFFSIDES
121Nephrotic SyndromeOFFSIDES
122Neurological decompensationOFFSIDES
123Ocular vascular disorderOFFSIDES
124OligohydramniosOFFSIDES
125OmphalitisOFFSIDES
126Oral fungal infectionOFFSIDES
127Oropharyngeal candidiasisOFFSIDES
128Ovarian adenomaOFFSIDES
129PROTHROMBIN TIMEOFFSIDES
130Pancreatic NeoplasmOFFSIDES
131Pancreatic PseudocystOFFSIDES
132PeritonitisOFFSIDES
133PertussisOFFSIDES
134PlasmacytomaOFFSIDES
135PolyneuropathyOFFSIDES
136Post procedural fistulaOFFSIDES
137Protein total increasedOFFSIDES
138Prothrombin level decreasedOFFSIDES
139PsoriasisOFFSIDES
140Pulmonary arterial hypertensionOFFSIDES
141QRS axis abnormalOFFSIDES
142QuadriparesisOFFSIDES
143Quality of life decreasedOFFSIDES
144RalesOFFSIDES
145Rectal tenesmusOFFSIDES
146Renal tubular disorderOFFSIDES
147Renin increasedOFFSIDES
148ReticulocytosisOFFSIDES
149Retrograde amnesiaOFFSIDES
150RhabdomyolysisOFFSIDES
151SclerodermaOFFSIDES
152Sick Sinus SyndromeOFFSIDES
153Sinoatrial BlockOFFSIDES
154Sinus bradycardiaOFFSIDES
155Skin lesionOFFSIDES
156Skin necrosisOFFSIDES
157Stevens-Johnson SyndromeOFFSIDES
158Sudden Cardiac DeathOFFSIDES
159Thalamic infarctionOFFSIDES
160ThrombophlebitisOFFSIDES
161Transaminases increasedOFFSIDES
162Troponin increasedOFFSIDES
163Urinary tract infection pseudomonalOFFSIDES
164VasospasmOFFSIDES
165Venous occlusionOFFSIDES
166Venous thrombosis limbOFFSIDES
167Ventricular FibrillationOFFSIDES
168Wound necrosisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.